Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000235386 encodes a pseudogene similar to part of microfibrillar-associated protein 2 (MFAP2), meaning it is a non-coding genomic region with sequence similarity to the MFAP2 gene but does not produce a functional protein. Pseudogenes generally arise from gene duplication or retrotransposition events and are not considered to have an active role as drug targets, disease drivers, or biomarkers. While the parent gene, MFAP2, encodes a protein involved in the extracellular matrix and various cancer and tissue processes, this pseudogene does not share those biological functions or therapeutic relevance[2]. ENSG00000235386 is a pseudogene, not a canonical therapeutic target or functional receptor/enzyme. It should not be included in drug target lists, and there is no evidence of biological activity, disease involvement, or drug interaction for this entry[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of microfibrillar-associated protein 2.